Cosmos Health (COSM) EBITDA (2010 - 2026)

Cosmos Health (COSM) has reported EBITDA for 17 consecutive years, with -$2.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA fell 10.43% year-over-year to -$2.8 million; the trailing twelve-month figure through Jun 2026 stood at -$18.1 million (down 26.47% YoY), and the FY2025 full-year result was -$16.3 million, down 7.32% from the prior year.
• EBITDA eased to -$2.8 million in Q2 2026 per COSM's latest filing, from -$2.1 million in the prior quarter.
• Across five years, EBITDA topped out at $327135.0 in Q1 2022 and bottomed at -$13.5 million in Q4 2023.
• Historically, EBITDA has averaged -$3.6 million across 5 years, with a median of -$2.4 million in 2023.
• The sharpest annual moves came in 2022 and 2023: EBITDA jumped 119.71% in 2022, then sank 39558.47% in 2023.
• Over 5 years, EBITDA stood at -$7.5 million in 2022, then plunged by 80.18% to -$13.5 million in 2023, then surged by 34.04% to -$8.9 million in 2024, then slipped by 28.37% to -$11.4 million in 2025, then jumped by 75.33% to -$2.8 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$2.8 million, -$2.1 million, and -$11.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.